Home/Filings/4/0000819050-22-000049
4//SEC Filing

McAvoy David R. 4

Accession 0000819050-22-000049

CIK 0000819050other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 4:17 PM ET

Size

5.5 KB

Accession

0000819050-22-000049

Insider Transaction Report

Form 4
Period: 2022-05-05
McAvoy David R.
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2022-05-05+300,000300,000 total
    Exercise: $0.26From: 2023-05-05Exp: 2032-05-05Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]The stock options will vest 25% on the first anniversary of the grant date, and the remainder will vest in equal monthly installments over the following three years.

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1
  • filerCIK 0001758842

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:17 PM ET
Size
5.5 KB